Know Cancer

or
forgot password

A Randomized, Multicenter, Open-label, Phase III Trial of Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected (D2) Gastric Cancer of Stage IIIB/IV (M0)


Phase 3
20 Years
N/A
Open (Enrolling)
Both
Gastric Adenocarcinoma

Thank you

Trial Information

A Randomized, Multicenter, Open-label, Phase III Trial of Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected (D2) Gastric Cancer of Stage IIIB/IV (M0)


Inclusion Criteria:



- Histologically proven, Stage IIIb/ IIIc curatively resected gastric carcinoma

- ECOG performance status 0-1

- Curatively resected advanced gastric cancer patients of stage IIIb/IIIc

- D2 lymph node dissection with R0 surgery

- Signed informed consent

Exclusion Criteria:

- Subjects with documented distant metastasis.

- Malabsorption syndrome or disease significantly affecting gastrointestinal function

- Patients with other uncontrolled systemic illness, e.g. infection, poorly controlled
HTN

- History of other malignancy. Subjects who have been disease-free for 5 years or
subjects with successfully treated in situ carcinoma are eligible.

- Subjects with preoperative/adjuvant other cancer treatment, such as chemotherapy,
immunotherapy and radiotherapy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

3-year disease free survival(DFS)

Outcome Description:

Tumor assessments with chest X-rays and CT or MRI scan will be done at 6 months after randomization (after the end of the treatment period), then every 3 months for the first 2 years after randomization and then every 6 months for coming 3 years then one year basis until completion of the study.

Outcome Time Frame:

3 years

Safety Issue:

No

Authority:

South Korea: Korea Food and Drug Administration (KFDA)

Study ID:

4-2009-0708

NCT ID:

NCT01283217

Start Date:

March 2010

Completion Date:

March 2016

Related Keywords:

  • Gastric Adenocarcinoma
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Stomach Neoplasms

Name

Location